Vitamin D3, the Liver and the Kidneys: Is It Safe?
Vitamin D3 is one of the most widely used supplements in the UK, recommended by public health bodies through the autumn and winter. Because it is processed by both the liver and the kidneys, people often ask whether supplements could strain these organs. Our editorial team explains how vitamin D metabolism works, where real risks lie and who needs medical supervision.
How the body processes vitamin D3
Vitamin D3 (cholecalciferol) is made in the skin when it is exposed to UVB light, and it is also obtained from oily fish, eggs, fortified foods and supplements. In itself it is biologically inactive and must be converted in two steps.
The first step happens in the liver, where vitamin D is converted to 25-hydroxyvitamin D, often called calcidiol. This is the main circulating form and the one measured in blood tests to assess vitamin D status.
The second step takes place mainly in the kidneys, where calcidiol is converted to 1,25-dihydroxyvitamin D, or calcitriol, the active hormone. This step is tightly regulated by parathyroid hormone, calcium and phosphate levels.
Because of this tight control, ordinary vitamin D supplements do not "force" the kidneys to make excess active hormone in healthy people. The body adjusts production to its needs, which is a key safety mechanism.
What UK guidance recommends
The Scientific Advisory Committee on Nutrition (SACN) set a reference nutrient intake of 10 micrograms (400 IU) per day for people aged four and over. The NHS advises everyone to consider this amount during autumn and winter, and all year round for people with little sun exposure or darker skin.
The tolerable upper intake level for adults, set by EFSA and used in the UK, is 100 micrograms (4,000 IU) per day. This is the amount considered safe for long-term daily use by the general population without medical monitoring.
| Measure | Value used in the UK | Comment |
|---|---|---|
| Reference nutrient intake (age 4+) | 10 µg (400 IU) per day | For the general population |
| Upper intake level (adults) | 100 µg (4,000 IU) per day | Not a target; a safety limit |
| Deficiency threshold (25(OH)D) | Below 25 nmol/L | SACN definition of low status |
| Range often associated with toxicity | Typically well above 375 nmol/L | Usually from prolonged high-dose use |
Doctors may prescribe higher "loading" doses for people with confirmed deficiency, typically for a few weeks. This is safe when done under medical supervision with follow-up blood tests.
Blood levels are measured in nanomoles per litre in the UK. When reading foreign studies or labs that use nanograms per millilitre, multiply by 2.5 to convert to nmol/L.
Vitamin D and the liver
For people with healthy livers, normal vitamin D supplementation poses no recognised risk of liver damage. The liver handles the first conversion step easily, and toxicity from supplements does not primarily affect the liver.
People with chronic liver disease, including cirrhosis and fatty liver, often have low vitamin D levels, partly because of impaired conversion and absorption. In these patients, supplements are commonly prescribed rather than restricted.
Some research has explored whether vitamin D could improve fatty liver disease. Results so far are inconsistent, and supplementation is not an established treatment for MASLD.
Certain medicines that affect liver enzymes, such as some anticonvulsants and rifampicin, increase vitamin D breakdown. People taking them may need higher doses, which should be decided by their doctor.
Vitamin D and the kidneys
The kidneys are more relevant to safety. The main harm from excess vitamin D is hypercalcaemia, an abnormally high level of calcium in the blood. Over time, this can lead to calcium deposits in the kidneys (nephrocalcinosis), kidney stones and reduced kidney function.
Toxicity is rare and usually results from prolonged use of very high doses, often tens of thousands of IU daily, sometimes due to manufacturing errors or misreading labels. Symptoms include thirst, frequent urination, nausea, constipation, confusion and fatigue.
In the Women's Health Initiative trial, women taking calcium plus a modest vitamin D dose had a small increase in kidney stones. This was probably driven mainly by the calcium. The large VITAL trial, using 2,000 IU daily, did not show significant harm to kidney function.
People with chronic kidney disease cannot make enough active vitamin D. They may be prescribed activated forms such as alfacalcidol or calcitriol, which bypass the kidney step. These are potent and require monitoring of calcium and phosphate, as outlined in the KDIGO guidelines.
Who needs extra caution
For most healthy adults, taking 10–25 micrograms (400–1,000 IU) daily is very unlikely to cause harm. Higher doses up to the upper limit are also generally safe, but there are groups for whom medical advice is essential.
- people with chronic kidney disease or a history of kidney stones;
- those with sarcoidosis, tuberculosis or other granulomatous diseases, which can produce active vitamin D outside the kidney;
- patients with primary hyperparathyroidism or high blood calcium;
- people taking thiazide diuretics, digoxin or high-dose calcium supplements;
- anyone already taking a prescribed vitamin D or activated vitamin D medicine.
Athletes sometimes take high-dose vitamin D in the belief that it boosts testosterone or performance. Evidence for performance benefits in people with adequate vitamin D status is weak, and very high doses offer no advantage while increasing risk.
Combination products can add up. Multivitamins, fish oils, fortified foods and stand-alone vitamin D all contribute to total intake. Check labels so that you do not unintentionally exceed the upper limit.
If you are unsure whether you need vitamin D at all, a 25-hydroxyvitamin D blood test arranged through your GP can clarify your status, especially if you have symptoms such as bone pain, muscle weakness or a history of low-trauma fractures.
Conclusions of the editorial team
Vitamin D3 is activated first in the liver and then in the kidneys, with tight regulation that protects healthy people from excessive activation.
At the doses recommended by UK guidance, vitamin D supplements are safe for the liver and kidneys in the general population. Harm almost always arises from prolonged very high doses leading to hypercalcaemia.
People with kidney disease, granulomatous disorders, high calcium or certain medicines need medical supervision. Everyone else should keep total intake within the 100-microgram upper limit.
For further reading, see our editorial guides on reading a vitamin D blood test, calcium supplements and bone health, and magnesium and vitamin D interactions.
References
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281.
- Scientific Advisory Committee on Nutrition. Vitamin D and Health. London: Public Health England; 2016.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate. EFSA J. 2023;21(8):e08145.
- Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669–683.
- Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44.
- Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D toxicity: a clinical perspective. Front Endocrinol (Lausanne). 2018;9:550.
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1–59.
